dc.contributor.author
Engelhardt, Pascal M.
dc.contributor.author
Florez-Rueda, Sebastián
dc.contributor.author
Drexelius, Marco
dc.contributor.author
Neudörfl, Jörg-Martin
dc.contributor.author
Lauster, Daniel
dc.contributor.author
Hackenberger, Christian P. R.
dc.contributor.author
Kühne, Ronald
dc.contributor.author
Neundorf, Ines
dc.contributor.author
Schmalz, Hans-Günther
dc.date.accessioned
2022-10-06T09:10:37Z
dc.date.available
2022-10-06T09:10:37Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/36098
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-35814
dc.description.abstract
During viral cell entry, the spike protein of SARS-CoV-2 binds to the α1-helix motif of human angiotensin-converting enzyme 2 (ACE2). Thus, alpha-helical peptides mimicking this motif may serve as inhibitors of viral cell entry. For this purpose, we employed the rigidified diproline-derived module ProM-5 to induce α-helicity in short peptide sequences inspired by the ACE2 α1-helix. Starting with Ac-QAKTFLDKFNHEAEDLFYQ-NH2 as a relevant section of α1, a series of peptides, N-capped with either Ac-βHAsp-[ProM-5] or Ac-βHAsp-PP, were prepared and their α-helicities were investigated. While ProM-5 clearly showed a pronounced effect, an even increased degree of helicity (up to 63 %) was observed in sequences in which non-binding amino acids were replaced by alanine. The binding affinities of the peptides towards the spike protein, as determined by means of microscale thermophoresis (MST), revealed only a subtle influence of the α-helical content and, noteworthy, led to the identification of an Ac-βHAsp-PP-capped peptide displaying a very strong binding affinity (KD=62 nM).
en
dc.format.extent
6 Seiten
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
CD spectroscopy
en
dc.subject
protein-protein interactions
en
dc.subject
secondary structures
en
dc.subject.ddc
500 Naturwissenschaften und Mathematik::540 Chemie::540 Chemie und zugeordnete Wissenschaften
dc.title
Synthetic α-Helical Peptides as Potential Inhibitors of the ACE2 SARS-CoV-2 Interaction
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
e202200372
dcterms.bibliographicCitation.doi
10.1002/cbic.202200372
dcterms.bibliographicCitation.journaltitle
ChemBioChem
dcterms.bibliographicCitation.number
17
dcterms.bibliographicCitation.volume
23
dcterms.bibliographicCitation.url
https://doi.org/10.1002/cbic.202200372
refubium.affiliation
Biologie, Chemie, Pharmazie
refubium.affiliation.other
Institut für Chemie und Biochemie
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
1439-7633
refubium.resourceType.provider
WoS-Alert